Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|September 10, 2014
Multiple sclerosis: a review of the disease and treatment optionsDaniel Sturm, Samuel L Gurevitz, Amelia Turner
Journal of Drugs in Dermatology : JDD|October 2, 2025
Ruxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic DermatitisLeon Kircik, Daniel Sturm, Howard Kallender, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 27, 2022
Origami Microwave Imaging Array: Metasurface Tiles on a Shape-Morphing Surface for Reconfigurable Computational ImagingSuresh Venkatesh, Daniel Sturm, Xuyang Lu, et al.
Dermatology and Therapy|March 7, 2024
Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient PerspectivesLawrence F Eichenfield, Jinan Liu, Simran Marwaha, et al.
Dermatology and Therapy|October 7, 2024
Efficacy and Safety of Ruxolitinib Cream in Atopic Dermatitis Based on Previous Medication HistoryAndrew Blauvelt, Howard Kallender, Daniel Sturm, et al.
Optics Express|November 14, 2024
Post-processing of phase change material in a zero-change commercial silicon photonic processUthkarsh Adya, Daniel Sturm, Rui Chen, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 11, 2025
Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims DatabaseJinan Liu, Karishma Desai, Chia-Chen Teng, et al.
Dermatology and Therapy|July 12, 2024
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 StudiesEric L Simpson, Leon Kircik, Andrew Blauvelt, et al.
American Journal of Clinical Dermatology|September 23, 2021
Psychosocial Effects of Vitiligo: A Systematic Literature ReviewKhaled Ezzedine, Viktoria Eleftheriadou, Heather Jones, et al.
Dermatology and Therapy|November 25, 2025
Use of Ruxolitinib Cream Results in Economic Benefits Compared with Dupilumab in Treatment of Patients with Atopic Dermatitis Meeting Severity Thresholds for Systemic TherapyOmar Noor, Jinan Liu, Daniel Sturm, et al.
Pageof 2